体重指数与初次全髋关节置换术后长期翻修风险及90天死亡率的相关性:来自英格兰、威尔士、北爱尔兰和马恩岛国家关节登记库的研究发现
基于国家关节登记库(NJR)2003年4月至2015年12月的数据,纳入415,598例初次全髋关节置换分析翻修、413,741例分析90天死亡率。调整年龄、性别、ASA分级、手术年份、指征和固定类型后,III级肥胖患者10年累积翻修概率最高(6.7%),为体重过低组(3.3%)的两倍;体重过低组90天死亡率风险显著升高(HR 2.09),而超重和I、II级肥胖组90天死亡风险显著低于正常BMI组。作者认为肥胖患者长期翻修率虽较高,但按当代标准仍可接受,且被较低的90天死亡风险所平衡。
要点
- III级肥胖患者10年累积翻修概率为6.7%,是体重过低组3.3%的两倍。
- 与正常BMI相比,I、II、III级肥胖患者翻修风险均显著升高,HR分别为1.14、1.30、1.43。
- 体重过低组90天死亡风险显著高于正常BMI组(HR 2.09),超重及I、II级肥胖组则显著较低。
核心结论
- 肥胖患者全髋关节置换术后长期翻修率较高,但作者认为按当代标准仍可接受,且被较低的90天死亡风险所平衡。
研究设计与样本
- 基于英格兰、威尔士、北爱尔兰和马恩岛国家关节登记库(NJR)的人群为基础纵向队列研究,使用2003年4月至2015年12月记录并链接英国国家统计局数据。
- 翻修分析纳入415,598例初次全髋关节置换,90天死亡率分析纳入413,741例,各数据集约占NJR记录手术总数的52%。
- 采用Kaplan-Meier法估计翻修概率,使用调整Cox比例风险回归模型分析BMI与翻修及死亡率的相关性。
主要发现
- 38%的患者被归类为肥胖;10年时III级肥胖患者累积翻修概率最高(6.7%[95%CI 5.5%至8.2%]),为体重过低组(3.3%[95%CI 2.2%至4.9%])的两倍。
- 调整年龄、性别、ASA分级、手术年份、指征和固定类型后,与正常BMI相比,I级肥胖(≥30至<35 kg/m²)翻修HR为1.14(95%CI 1.07至1.22),II级肥胖(≥35至<40 kg/m²)HR为1.30(95%CI 1.19至1.40),III级肥胖(≥40至≤60 kg/m²)HR为1.43(95%CI 1.27至1.61),均p<0.0005。
- 体重过低患者90天累积死亡概率为1.17%(95%CI 0.86%至1.58%),正常BMI组为0.43%(95%CI 0.39%至0.48%)。
- 与正常BMI相比,体重过低组90天死亡风险显著升高(HR 2.09[95%CI 1.51至2.89],p<0.0005);超重组显著降低(HR 0.70[95%CI 0.61至0.81],p<0.0005),I级肥胖组HR 0.69(95%CI 0.59至0.81,p<0.0005),II级肥胖组HR 0.79(95%CI 0.63至0.98,p=0.049)。
关键数值与推荐
- BMI分类界值:I级肥胖≥30至<35 kg/m²,II级肥胖≥35至<40 kg/m²,III级肥胖≥40至≤60 kg/m²。
- 证据等级:预后Level III。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The influence of obesity on outcomes following total hip replacement is unclear. Restriction of total hip replacement on the basis of body mass index (BMI) has been suggested. The purpose of this study was to assess the influence of BMI on the risk of revision and 90-day mortality. METHODS: This was a population-based, longitudinal cohort study of the National Joint Registry (NJR) for England, Wales, Northern Ireland and the Isle of Man. Using data recorded from April 2003 to December 2015, linked to Office for National Statistics data, we ascertained revision and 90-day mortality rates following primary total hip replacement by BMI category. The probability of revision was estimated using Kaplan-Meier methods. Associations of BMI with revision and mortality were explored using adjusted Cox proportional hazards regression models. RESULTS: We investigated revision and 90-day mortality among 415,598 and 413,741 primary total hip replacements, respectively. Each data set accounts for approximately 52% of the total number of recorded operations in the NJR. Thirty-eight percent of the patients were classified as obese. At 10 years, class-III obese patients had the highest cumulative probability of revision (6.7% [95% confidence interval (CI), 5.5% to 8.2%]), twice that of the underweight group (3.3% [95% CI, 2.2% to 4.9%]). When the analysis was adjusted for age, sex, American Society of Anesthesiologists [ASA] grade, year of operation, indication, and fixation type, compared with patients with normal BMI, significantly elevated hazard ratios (HRs) for revision were observed for patients in the BMI categories of class-I obese (≥30 to <35 kg/m) (HR, 1.14 [95% CI, 1.07 to 1.22]), class-II obese (≥35 to <40 kg/m) (HR, 1.30 [95% CI, 1.19 to 1.40]), and class-III obese (≥40 to ≤60 kg/m) (HR, 1.43 [95% CI, 1.27 to 1.61]) (p < 0.0005 for all). Underweight patients had a substantially higher cumulative probability of 90-day mortality (1.17%; 95% CI, 0.86% to 1.58%) compared with patients with normal BMI (0.43%; 95% CI, 0.39% to 0.48%). The risk of 90-day mortality was significantly higher for the underweight group (HR, 2.09 [95% CI, 1.51 to 2.89]; p < 0.0005) and significantly lower for patients who were categorized as overweight (HR, 0.70; 95% CI, 0.61 to 0.81; p < 0.0005), class-I obese (HR, 0.69 [95% CI, 0.59 to 0.81]; p < 0.0005), and class-II obese (HR, 0.79 [95% CI, 0.63 to 0.98]; p = 0.049) compared with patients with normal BMI. CONCLUSIONS: Although long-term revision rates following total hip replacement were higher among obese patients, we believe that the rates remained acceptable by contemporary standards and were balanced by a lower risk of 90-day mortality. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Mouchti S, Whitehouse MR, Sayers A, et al. The Association of Body Mass Index with Risk of Long-Term Revision and 90-Day Mortality Following Primary Total Hip Replacement: Findings from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man. J Bone Joint Surg Am. 2018. PMID: 30562295. doi:10.2106/JBJS.18.00120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。